ROSS vs AARD
Comparison between Ross Acquisition Corp II - Class A (ROSS, Company) and Aardvark Therapeutics Inc (AARD, Company).
ROSS is from the Financial Services sector, while AARD is from the Healthcare sector.
ROSS vs AARD - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
ROSS vs AARD - Historical Returns
Returns include dividend reinvestment.
ROSS vs AARD - Annual Returns (2021 - 2026)
Returns include dividend reinvestment.
| Year | ROSS | AARD |
|---|---|---|
| 2026 | +0.00% | -44.66% |
| 2025 | +0.00% | -8.28% |
| 2024 | +1.74% | N/A |
| 2023 | +7.62% | N/A |
| 2022 | +4.01% | N/A |
| 2021 | -0.10% | N/A |
ROSS vs AARD Drawdown Comparison
The maximum drawdown for ROSS was -3.40%, occurring on Sep 16, 2021. Recovery took 303 trading sessions.
The maximum drawdown for AARD was -80.01%, occurring on Jun 10, 2026. This drawdown has not yet recovered.
The current ROSS drawdown is -0.36%. The current AARD drawdown is -58.07%.
| Rank | ROSS | AARD |
|---|---|---|
| #1 | -3.40% Aug 25, 2021 - Nov 7, 2022 | -80.01% Oct 7, 2025 - Jun 10, 2026 |
| #2 | -3.01% May 11, 2021 - Aug 25, 2021 | -59.42% Feb 20, 2025 - Oct 7, 2025 |
| #3 | -1.62% May 4, 2021 - May 11, 2021 | -7.06% Feb 13, 2025 - Feb 19, 2025 |
| #4 | -0.84% Nov 16, 2022 - Dec 23, 2022 | N/A |
| #5 | -0.84% Aug 15, 2023 - Sep 5, 2023 | N/A |
| #6 | -0.76% Jun 13, 2023 - Jun 26, 2023 | N/A |
| #7 | -0.75% Jul 24, 2023 - Jul 27, 2023 | N/A |
| #8 | -0.64% Jan 29, 2024 - Feb 6, 2024 | N/A |
| #9 | -0.59% Apr 14, 2023 - May 18, 2023 | N/A |
| #10 | -0.58% May 30, 2023 - Jun 13, 2023 | N/A |
| #11 | -0.55% Dec 26, 2023 - Jan 22, 2024 | N/A |
| #12 | -0.54% Jan 23, 2024 - Jan 29, 2024 | N/A |
| #13 | -0.47% Jul 28, 2023 - Aug 1, 2023 | N/A |
| #14 | -0.47% Aug 1, 2023 - Aug 15, 2023 | N/A |
| #15 | -0.39% Mar 7, 2023 - Mar 14, 2023 | N/A |
Correlation
Correlation between ROSS and AARD is 0.00 which considered as a very weak or no correlation - the stocks move independently of each other.
Select Stocks to Compare
More Comparisons
Compare with similar stocks